A critical question for cancer therapy: what new targets exist?

Designing molecular targeted therapy with high specificity based on novel tumor biomarkers is a high priority in lung cancer research. Several molecular aberrations have been already identified in non-small cell lung cancer (NSCLC), with subsequent development of drugs targeted to these aberrations....

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Main Authors: Rosell, Rafael, Karachaliou, Niki, Codony, Jordi, Teixido, Cristina, Garcia-Roman, Silvia, Morales, Daniela, Cao, María González, Viteri, Santiago, Veliz, Ignacio, Loo, Yong, Castillo, Omar
Formato: Artigo
Idioma:Inglês
Publicado: Pioneer Bioscience Publishing Company 2014
Assuntos:
Editorial
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4367674/
https://ncbi.nlm.nih.gov/pubmed/25806328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2014.08.10
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares